- Home >
- Life Sciences >
- Biotechnology >
- Biopharmaceutical >
Biopharmaceutical Industry Analysis and Statistics (since 2008)
Refine results by
Top countries
Publication dates
All countries
All premium reports for Biopharmaceutical Industry Analysis and Statistics (since 2008)
1-9 of 9 Premium Reports from 3 Publishers
R&D Pipeline News - Technology Edition: 1-Year Subscription
- $ 1 000
- October 2009
Product description R&D Pipeline News is your weekly tool for analysis of biopharmaceutical R&D. It is available by monthly or annual subscription. The annual subscription consists of 50 issues, the monthly of four or five issues. R&D Pipeline News Technology Edition will keep you up-to-date ...
Industries : Biopharmaceutical
R&D Pipeline News - Therapeutic Area Edition: 1-Year Subscription
- $ 1 000
- October 2009
Product description R&D Pipeline News is your weekly tool for analysis of biopharmaceutical R&D. It is available by monthly or annual subscription. The annual subscription consists of 50 issues, the monthly of four or five issues. R&D Pipeline News Therapeutic Area Edition will keep you up-to ...
Industries : Biopharmaceutical
Biosimilars (2009 - 2014)
- $ 4 650
- September 2009
Report DescriptionThe impending expiry of several patented blockbuster biopharmaceuticals and the increasing demand from patients, insurers, and government agencies to reduce drug costs have created numerous opportunities in the global biosimilars market. The global biosimilars market is expected to ...
Industries : Biopharmaceutical
Global Biopharmaceuticals Industry Report
- $ 1 313
- September 2009
The Global Biopharmaceuticals Industry ReportDo you know....The top 7 best trading partners in the industry?Which company has the highest sales growth?Which companies have the highest levels of debt?This report is an in-depth financial evaluation of the Global Biopharmaceuticals Industry. Using the ...
Industries : Biopharmaceutical
Competitor Analysis: Raf Inhibitors
- $ 250
- May 2009
Product description The present Competitive Intelligence Report about Raf inhibitors provides a competitor evaluation in the field of synthetic molecules targeting Raf and mutant Raf (V600E) for treatment of cancer as of May 2009. The mitogen activated protein kinases (MAPKs) are conserved pro ...
Industries : Biopharmaceutical
Competitor Analysis: NGF Agonists & Antagonists
- $ 125
- May 2009
Product description The present Competitive Intelligence Report about Nerve Growth Factor (NGF) Agonists & Antagonists provides a competitor evaluation in the field of investigational antibodies, small molecules and gene therapeutic approaches for treatment of chronic pain or Alzheimer&rsq ...
Industries : Biopharmaceutical
Competitor Analysis: PARP Inhibitors
- $ 125
- April 2009
Product description The present Competitive Intelligence Report about PARP Inhibitors provides a competitor evaluation in the field of investigational small molecules inhibiting poly-adenyl-ribose polymerase (PARP) for treatment of cancer as of April 2009. Poly (ADP-ribose) polymera ...
Industries : Biopharmaceutical
Competitor Analysis: EpCAM Antagonists
- $ 125
- April 2009
Product description The present Competitive Intelligence Report about EpCAM Antagonists provides a competitor evaluation in the field of investigational antibodies and antibody-based constructs targeting epithelial cell adhesion molecule (EpCAM) for treatment of cancer as of April 2009. Epith ...
Industries : Biopharmaceutical
Competitor Analysis: p38 MAPK Inhibitors
- $ 250
- March 2009
Product description The present Competitive Intelligence Report about p38 MAPK inhibitors used to treat inflammatory diseases such as rheumatoid arthritis, psoriasis, COPD or pemphigus vulgaris and pain, respectively, provides a competitor evaluation in the field of R&D projects with p38 MAPK inh ...
Industries : Biopharmaceutical
reportlinker.com © Copyright 2009. All rights reserved